Acadia Pharmaceuticals

ACAD

27.55

-0.46

-1.6%

After Hours:

27.45

-0.10

-0.4%

Stock Price
Open: 28.09
Prev. Close: 28.01
Low/Hi: 27.28 - 28.30
52-Week: 20.68 - 42.49
Volumes
Equity: 1,220,061
90-Day Avg: 1,828,369
Option: 1,045
90-Day Avg: 3,101
Volatility
Today: 32.8
20-Day: 39.3
52-Week: 52.5
30-Day IV: 52.9 +0.6
IV Rank: 0.34 (Subdued)
Fundamental
Div. Yield: 0.0%
Earnings: 4-Aug (Est.)
P/E Ratio:
Market Cap: 3.4 B
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

ACAD Balance Sheet

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 31-Mar-2017 31-Dec-2016 30-Sep-2016 30-Jun-2016
Cash and Cash Equivalents 157,383 163,620 153,679 131,774
Short Term Investments 312,098 365,416 435,180 280,781
Investments - - - -
Accounts Receivable 9,519 7,140 5,224 1,633
Inventory 3,881 4,175 4,301 2,867
Loans - - - -
Prepaid Expenses 6,872 7,546 5,106 6,842
Net Property Plant and Equipment 3,471 3,081 3,159 2,897
Other Current Assets 0 0 0 0
Current Assets 489,753 547,897 603,490 423,897
Goodwill and Intangibles 6,646 7,015 7,385 7,754
Long Term Investments 0 0 0 0
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 503,013 561,153 617,384 438,034
Short Term Debt 0 0 0 0
Other Non-Current Assets 3,143 3,160 3,350 3,486
Accounts Payable 2,166 3,912 2,828 1,024
Accrued Liabilities and Other Payables 38,967 36,029 34,445 27,485
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 45,489 42,742 39,326 29,219
Other Current Liabilities 4,132 2,644 1,876 513
Accumulated Other Comprehensive Income 94 106 533 206
Preferred Stock 0 0 0 0
Current Liabilities 45,265 42,585 39,149 29,022
Common Stock 12 12 12 11
Other Non-Current Liabilities 224 157 177 197
Additional Paid-In Capital 1,479,530 1,452,272 1,432,796 1,192,268
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -1,022,112 -933,979 -855,283 -783,670
Total Equity 457,524 518,411 578,058 408,815
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014 31-Dec-2013
Cash and Cash Equivalents 163,620 102,138 61,854 11,707
Short Term Investments 365,416 112,994 260,632 174,083
Investments - - - -
Accounts Receivable 7,140 1,638 964 0
Inventory 4,175 0 0 0
Loans - - - -
Prepaid Expenses 7,546 2,219 1,168 2,570
Net Property Plant and Equipment 3,081 2,203 553 579
Other Current Assets 0 0 0 0
Current Assets 547,897 218,989 324,618 188,360
Goodwill and Intangibles 7,015 0 0 0
Long Term Investments 0 0 0 0
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 561,153 221,896 325,458 189,118
Short Term Debt 0 0 0 0
Other Non-Current Assets 3,160 704 287 179
Accounts Payable 3,912 1,672 2,016 372
Accrued Liabilities and Other Payables 36,029 20,230 13,818 6,552
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 42,742 22,134 15,969 6,987
Other Current Liabilities 2,644 0 0 55
Accumulated Other Comprehensive Income 106 11 -9 48
Preferred Stock 0 0 0 0
Current Liabilities 42,585 21,902 15,834 6,979
Common Stock 12 10 10 9
Other Non-Current Liabilities 157 232 135 8
Additional Paid-In Capital 1,452,272 862,327 807,631 587,742
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -933,979 -662,586 -498,143 -405,668
Total Equity 518,411 199,762 309,489 182,131